Additional Details
-
Tocilizumab in Lung Transplantation
Columbia University Medical Center (Site #: 71113)New York NY. 10032View Details -
Tocilizumab in Lung Transplantation
University of Texas Southwestern (Site #: 71187)Dallas TX. 75390View Details -
Tocilizumab in Lung Transplantation
University of Utah Medical Center (Site #: 71126)Salt Lake City UT. 84132View Details -
Tocilizumab in Lung Transplantation
Duke University Medical Center (Site #: 71139)Durham NC. 27710View Details -
Tocilizumab in Lung Transplantation
Cedars Sinai Medical Center (Site #: 71146)Los Angeles CA. 90048View Details -
Tocilizumab in Lung Transplantation
David Geffen School of Medicine at UCLA (Site #: 71123)Los Angeles CA. 90095View Details -
Tocilizumab in Lung Transplantation
Massachusetts General Hospital (Site #: 71107)Boston MA. 02114View Details -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
UCLA Health Westwood Medical PlazaWestwood CA. 90095View Details -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
NewportNativeMD, Inc.Newport Beach CA. 92663-3661View Details -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Local Institution - 0392Wilmington NC. 28401-7307View Details -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Beaumont Hospital, Royal OakRoyal Oak MI. 48073-6712View Details -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Diex Recherche - Trois-RivieresTrois-Rivières QC. G9S4P3View Details -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Local Institution - 0102Québec QC. G1V 4G5View Details -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Medstar Georgetown University HospitalWashington D.C. DC. 20007-2113View Details -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
C.I.C. JolietteSaint-Charles-Borromée QC. J6E 2B4View Details -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Washington University School of Medicine in St. LouisSt Louis MO. 63110-1010View Details -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
C.I.C. Mauricie Inc.Trois-Rivières QC. G8T 7A1View Details -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Coastal Pulmonary & Critical Care, P.L.C.St. Petersburg FL. 33704View Details -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Renown Regional Medical CenterReno NV. 89502-1576View Details -
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
Kelowna Respiratory & Allergy ClinicKelowna BC. V1W 1V3View Details
